Verona Pharma (VRP)

 

Latest News

Verona Pharma Appoints Dr. Desiree Luthman as Vice President of Regulatory Affairs

Verona Pharma Appoints Dr. Desiree Luthman as Vice President of Regulatory Affairs LONDON, June 22, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, today announces the...

Verona Pharma plc : Holding(s) in Company

Verona Pharma plc: Holding(s) in Company TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Verona Pharma Plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or dispo...

Verona Pharma plc : Holding(s) in Company

Verona Pharma plc: Holding(s) in Company For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Verona Pharma plc 2 Reason for the notification (please tick the appropr...

Verona initiates US clinical pharmacokinetic study for RPL554

Verona Pharma has announced the initiation of a clinical pharmacokinetic trial in the US for its product candidate RPL55...

All News

DateHeadlineSource
22-06-17Verona Pharma Appoints Dr. Desiree Luthman as Vice President of Regulatory AffairsRNS
06-06-17Verona Pharma plc : Holding(s) in CompanyRNS
06-06-17Verona Pharma plc : Holding(s) in CompanyRNS
05-06-17Verona initiates US clinical pharmacokinetic study for RPL554StockMarketWire
05-06-17Verona Pharma Initiates U.S. Clinical Pharmacokinetic Study for RPL554 Following Acceptance of IND Application by FDARNS
30-05-17Holding(s) in CompanyRNS
30-05-17Holding(s) in CompanyRNS
25-05-17Holding(s) in CompanyRNS
25-05-17Verona Pharma Announces Further Exercise of Over-Allotment Option and Resulting Total Voting RightsRNS
23-05-17Verona CEO to present at Jefferies Healthcare ConferenceStockMarketWire
23-05-17Verona Pharma to Present at Jefferies 2017 Global Healthcare ConferenceRNS
23-05-17Holding(s) in CompanyRNS
22-05-17Broker Forecast - Jefferies International issues a broker note on Verona Pharma PLCStockMarketWire
16-05-17Partial Exercise of Over-Allotment OptionRNS
08-05-17Holding(s) in CompanyRNS
05-05-17Holding(s) in CompanyRNS
05-05-17Holding(s) in CompanyRNS
05-05-17Holding(s) in CompanyRNS
03-05-17Holding(s) in CompanyRNS
03-05-17Block Listing Application and ReviewRNS
03-05-17Grant of Options and RSUs and PDMR DealingsRNS
02-05-17Closing of Global Offering and Total Voting RightsRNS
02-05-17Director/PDMR ShareholdingRNS
28-04-17Director Deals - Verona Pharma PLC (VRP)StockMarketWire
28-04-17Director/PDMR ShareholdingRNS
27-04-17Pricing of Offering and Approval to List on NASDAQRNS
19-04-17Global Offering and Application to List on NASDAQRNS
18-04-17FDA authorises start of Verona Pharma's US trialStockMarketWire
18-04-17FDA Authorisation to Proceed RPL554 InvestigationRNS
12-04-17All resolutions passed at Verona AGMStockMarketWire
12-04-17Result of AGMRNS
04-04-17Files Statement for Proposed Global OfferingRNS
04-04-17Files Statement for Proposed Global OfferingRNS
04-04-171st Patient Dosed in Ph2a Trial for RPL554 in CFRNS
03-04-17Board ChangeRNS
31-03-17COPD Collaboration and New Commercial DirectorRNS
22-03-17Verona Pharma in services agreement with QuintilesIMSStockMarketWire
22-03-17Services Agreement with QuintilesIMSRNS
20-03-17Verona Pharma schedules AGMStockMarketWire
20-03-17Posting of Annual report & Notice of AGMRNS

RSS feeds

  • Editorial news feed for LSE:VRP Editorial
  • Regulatory news feed for LSE:VRP Regulatory